Saudi Arabia and the UAE have emerged as the primary drivers of healthcare investment in the Gulf, accounting for 92% of nearly 400 deals since 2021.
According to JLL, both nations are rapidly expanding healthcare infrastructure under Saudi Vision 2030 and the UAE’s 2023–2026 health strategy.
This wave of activity highlights the Gulf’s growing appeal for global and regional investors.
Demographic growth and rising health awareness are shaping demand for advanced healthcare services.
A young, tech-savvy population is pushing preventive care and digital health adoption, while an ageing group drives chronic disease management.
By 2030, the GCC population is projected to reach nearly 70 million, intensifying healthcare needs.
Digitalization is playing a transformative role across the sector.
Saudi Arabia’s unified electronic records system and the UAE’s Riayati platform are reshaping patient access and efficiency.
These innovations, coupled with global tech partnerships, are attracting health-tech investments, from AI diagnostics to telemedicine.
The deal landscape spans early-stage funding in mental health, wellness, and home care to large M&A in hospitals and clinics.
Between 2021 and 2025, the region recorded 170 early-stage rounds and 91 acquisitions, backed by sovereign funds like Mubadala and ADQ.
Notably, Saudi Arabia’s Almoosa Health IPO raised $450 million in 2025, underscoring investor appetite.
Looking ahead, growth is set to accelerate in preventive medicine, personalized healthcare, and smart health technologies.
Investments are likely to target genetic testing, longevity programs, and advanced monitoring platforms.
For investors, the GCC offers not only strong returns but also a chance to shape the future of healthcare for millions.
Leave a Comment